Company announcements

Dealing in securities

September 25, 2020

---

Johannesburg, Friday, 25 September 2020. In compliance with paragraphs 3.63 to 3.74 of the JSE Listings Requirements, the following information is disclosed:

1. VESTING IN SHARE APPRECIATION RIGHTS AND SALE OF ORDINARY SHARES BY PRESCRIBED OFFICER

The following transactions are disclosed in relation to SARS:   

Name of director:	VP Tobias (Prescribed Officer)
Nature of transaction:	The off-market issuance of shares to settle SARS
Date of vesting of SARS issued in 2014:	17 November 2019
Number of 2014 SARS vested to date:	15 618
2014 SARS issue value per share:	R18.41
1-day Volume Weighted Average price of shares	R96.0163
Nature of transaction:	On market sale of shares
Number of ordinary shares issued to settle 2014 SARS:	12 623
Date of sale:	18 September 2020
Selling price per share:	R94.0390
Day highest sale price:	R95.8200
Day lowest sale price:	R91.5100
Proceeds for total on market sale:	R1 187 054.30
Class of Securities:	Ordinary Shares
Nature and extent of prescribed officer’s interest:	Direct beneficial

Prior clearance was obtained in respect of the above dealings by the prescribed officer.

For more details contact:

Marian van der Walt
Senior Group Executive: Enterprise Risk and Investor Relations
+27(0)82 888 1242 (mobile)

Max Manoeli
Senior Investor Relations Coordinator
+27(0)82 759 1775 (mobile)

Johannesburg, South Africa
25 September 2020

Sponsor:
J.P. Morgan Equities South Africa Proprietary Limited